• linkedin
  • Increase Font
  • Sharebar

    Updates to MAPP project top interstitial cystitis/bladder pain syndrome highlights

    This article is part of the State of Urology 2014

    Philip M. Hanno, MD, MPHDr. Hanno

    The most informative presentations on interstitial cystitis/bladder syndrome (IC/BPS) at the 2014 AUA annual meeting will be a plenary talk by J. Quentin Clemens, MD, updating attendees on the National Institute of Diabetes and Digestive and Kidney Diseases’ Multidisciplinary Approach to Pelvic Pain (MAPP) project and an abstract providing long-term follow-up on the use of cyclosporine A in patients with refractory IC, according to Philip M. Hanno, MD, MPH.

    “The search for the etiology of BPS and how findings might relate to treatment is the major emphasis of this AUA,” said Dr. Hanno, professor of urology at the University of Pennsylvania, Philadelphia. “In Plenary Session II, presentations regarding updates to the MAPP project (which is focusing on relationships to yield insight into pathophysiology and potential treatments), asymptomatic bacteria in urologic disease, and the role of the gastrointestinal tract in urologic disease are all potentially important in this regard.

    “The session on BPS Saturday afternoon is highlighted by several presentations on etiology and other presentations on new treatments in animal models that may lead to clinical trials in the future. It appears there is much work to be done before new treatments will enter the clinical armamentarium,” Dr. Hanno added. “Until then, the treatment of BPS will continue to be more ‘art’ than ‘science.’ ”

    Here's what Dr. Hanno says to watch for in the field of IC/BPS:

    Plenary II, Monday, May 19 at 10:50 am: State-of-the-Art Lecture: Role of Asymptomatic Bacteriuria in Urologic Disease
    David J. Klumpp, PhD

    Plenary II, Monday, May 19 at 11:20 am: Update on the MAPP Project
    J. Quentin Clemens, MD

    PD9-10: Prospective Long-term Follow-up Study of Patients with Refractory Interstitial Cystitis treated with Cyclosporine A
    Jamil Chade

    Subscribe to Urology Times to get monthly news from the leading news source for urologists.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results